STD Diagnostics Market Report 2026

STD Diagnostics Market Overview

• STD Diagnostics market size has reached to $10.77 billion in 2025 • Expected to grow to $17.52 billion in 2030 at a compound annual growth rate (CAGR) of 10.1% • Growth Driver: Surging Global Prevalence Of STDs Sparks Momentum In The STD Diagnostics Market • Market Trend: Advancements in STD Diagnostics through Real-Time PCR Kit Innovations • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under STD Diagnostics Market?

STDs (sexually transmitted diseases) diagnostics refers to analyzing and identifying infectious illnesses spread by sexual contact from an infected person to a healthy person. STD diagnostics are used to detect whether an individual has been infected with sexually transmitted diseases. The main types of STD diagnostics are chlamydia testing, syphilis testing, gonorrhea testing, herpes simplex virus testing, human papilloma virus testing, human immunodeficiency virus testing, chancroid testing, and others conducted in a laboratory testing and point of care (POC) testing settings. Chlamydia testing is a diagnostic test involving a urine test which is then analyzed for the detection of infection. Chlamydia testing is used for the detection of chlamydia infection. A typical sexually transmitted infection (STI) brought on by bacteria is chlamydia. It can be spread by oral, vaginal, or anal intercourse without the use of a barrier technique like a condom, as well as through genital touch and vaginal discharge or semen. The STD diagnostics are used by hospitals and clinics, diagnostic centers, and homecare.

What Is The STD Diagnostics Market Growth Forecast?

The std diagnostics market size is expected to see rapid growth in the next few years. It will grow to $17.52 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to increasing demand for rapid diagnostics, rising adoption of home-based testing kits, expansion of molecular diagnostics penetration, growing investments in public health surveillance, increasing focus on confidential and accessible testing services. Major trends in the forecast period include increasing adoption of rapid and point-of-care std tests, rising use of molecular diagnostic technologies, growing integration of automated laboratory systems, expansion of at-home std testing solutions, enhanced focus on early and accurate disease detection.

Global STD Diagnostics Market Segmentation

1) By Type: Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, Chancroid Testing 2) By Location Of Testing: Laboratory Testing, Point Of Care (PoC) Testing 3) By End-User: Hospitals And Clinics, Diagnostic Centers, Homecare Subsegments: 1) By Chlamydia Testing: Nucleic Acid Amplification Tests (NAAT), Antigen Tests 2) By Syphilis Testing: Rapid Plasma Reagin (RPR) Tests, Treponemal Tests 3) By Gonorrhea Testing: Nucleic Acid Amplification Tests (NAAT), Culture Tests 4) By Herpes Simplex Virus Testing: PCR Tests, Serological Tests 5) By Human Papilloma Virus Testing: HPV DNA Tests, HPV RNA Tests 6) By Human Immunodeficiency Virus Testing: Antibody Tests, Antigen Or Antibody Tests, Nucleic Acid Tests (NAT) 7) By Chancroid Testing: Culture Tests, Nucleic Acid Tests

What Is The Driver Of The STD Diagnostics Market?

The growing prevalence of STDs is expected to propel the growth of the STD diagnostics market going forward. STDs, or sexually transmitted diseases, are infections transmitted through sexual contact that require medical diagnosis and treatment. The rising prevalence of STDs is driven by increased sexual activity and changing social behaviors among younger populations, as reduced stigma around sexual health and greater mobility lead to more diverse sexual networks and higher transmission rates. Growing STD prevalence directly supports increased demand for diagnostic testing services and products as healthcare providers require accurate laboratory tests, screening kits, and detection technologies to identify infections and prevent further transmission. For instance, in September 2025, according to the Centers for Disease Control and Prevention, a US-based government administration, congenital syphilis rose for the twelfth consecutive year, reaching nearly 4,000 reported cases in 2024. Therefore, the growing prevalence of STDs is driving the growth of the STD diagnostics industry.

Key Players In The Global STD Diagnostics Market

Major companies operating in the std diagnostics market are Abbott Laboratories, Qiagen Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Bio-Rad Laboratories Inc., Becton Dickinson and Company, Thermo Fisher Scientific Inc., Biocartis NV, Trinity Biotech PLC, Binx Health Inc., NOWDiagnostics Inc., Atlas Genetics Ltd., BioFire Diagnostics LLC, BioMérieux SA, Chembio Diagnostic Systems Inc., Corgenix Medical Corporation, Creative Diagnostics, Curetis AG, Daktari Diagnostics, Enzo Biochem Inc., Fujirebio Diagnostics Inc., GenePOC Inc., GenMark Diagnostics Inc., Grifols Diagnostic Solutions Inc., Hain Lifescience GmbH, Luminex Corporation, Meridian Bioscience Inc., Mesa Biotech Inc., Mobidiag Oy

Global STD Diagnostics Market Trends and Insights

Major companies operating in the STD diagnostics market are focused on developing innovative products, such as real time PCR kit, to address unmet medical needs and enhance diagnostic capabilities. A real-time PCR kit is a collection of reagents used to perform real-time polymerase chain reaction (qPCR), a sensitive and widely used technique for detecting and quantifying specific nucleic acid sequences. For instance, in March 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a China-based research and development company, launched the Mycoplasma Hominis Real Time PCR Kit and the Treponema Pallidum Real Time PCR Kit, which are designed for the detection of Mycoplasma hominis and Treponema pallidum. Moreover, these are high sensitivity and specificity, ease of use, rapid turnaround time, and the ability to detect multiple pathogens in a single test.

What Are Latest Mergers And Acquisitions In The STD Diagnostics Market?

In February 2024, Thyrocare, an India-based Healthcare company, acquired Think Health Care for undisclosed amount. This acquisition Thyrocare aims to strategically enhance Thyrocare's service offerings and market reach, particularly in the home healthcare segment. Think Health Care is an India-based diagnostic and preventive healthcare company. that provided at-home ECG services.

Regional Outlook

North America was the largest region in the STD diagnostics market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the STD Diagnostics Market?

The STD diagnostics market consists of revenues earned by entities by providing STD diagnostics tests such as cultural/isolated tests of organisms, molecular tests, and immunology assays. The market value includes the value of related goods sold by the service provider or included within the service offering. The STD diagnostics market also includes sales of thermal cyclers, PCR, lateral flow readers – immuno chromatographic assays, flow cytometers, differential light scattering machines, absorbance microplate readers, phone chips, and rapid diagnostic kits which are used in providing STD diagnostic services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.